Completed PHASE4 INTERVENTIONAL 3-arm NCT02189239

Efficacy Study of Zeller Entspannung Film Coated Tablets on Acute Stress

A Phase IV, Randomised, Placebo Controlled Study to Investigate the Effects of Zeller Entspannung Film Coated Tablets on Cortisol Responses in Healthy Volunteers With Acute Stress

Sponsor: Max Zeller Soehne AG

Conditions The Primary Condition Studied for This Trial is Acute Stress

Interventions No Treatment Placebo Zeller Entspannung film coated tablet

Updated 5 times since 2017 Last updated: Jun 24, 2015 Started: Jan 31, 2015 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on The Primary Condition Studied for This Trial is Acute Stress, this trial is completed. The trial is conducted by Max Zeller Soehne AG and has accumulated 5 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Max Zeller Soehne AG

Data source: Max Zeller Soehne AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Basel, Switzerland